Children's Tumor Foundation

DENVER, CO — The Children’s Tumor Foundation (CTF) will bring the global neurofibromatosis and schwannomatosis community to Denver this summer for two major convenings...

Elizabeth Cavanaugh

Three years ago, Elizabeth Cavanaugh wasn’t sure she could run a marathon. But when she learned about the Children’s Tumor Foundation’s NF Endurance team ...

Research funded by the Children’s Tumor Foundation (CTF) is helping to answer one of the most complex questions in NF: how benign tumors transform into aggressive cancers, and how to stop that process.

The Young Investigator Award (YIA) provides two-year salary support to early-career NF researchers to help them get established as independent NF investigators and pursue bold, innovative projects designed to improve care and uncover new treatments for people living with NF. Since its inception, several YIAs have made groundbreaking research findings a...

The Children’s Tumor Foundation (CTF) has launched a global initiative to develop evidence-informed, consensus-based recommendations for the diagnosis of neurofibromatosis type 1 (NF1) and all forms of schwannomatosis (SWN, including NF2-related schwannomatosis, or NF2-SWN), and for the management of their associated manifestations. The approach to care for individuals with N...